Clinical Trial Update: Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated potential drug-drug interactions between EDP-305 and the antifungals itraconazole and rifampin in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• EDP-305
• Itraconazole (Itraconazole)
• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: Enanta Pharmaceuticals, Inc | Conditions: NASH - Nonalcoholic Steatohepatitis | Phase 1 | Status: COMPLETED